Clinical Trials Logo

Clinical Trial Summary

Aim is to investigate the effect of beta2 adrenergic stimulant salbutamol on emotional and cognitive functions in healthy humans.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01957293
Study type Interventional
Source University of Basel
Contact
Status Completed
Phase Phase 2
Start date October 2013
Completion date February 2014

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03823183 - Multi-domain Versus Uni-Domain Training on Executive Control and Memory Functions of Older Adults N/A
Completed NCT01599962 - Influence of Cincalcet on Cognitive Functions in Healthy Human Subjects Phase 2